JUPITER NEUROSCIENCES, INC.
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 |
|---|---|---|---|---|
| Income Statement | ||||
| Revenue | $21,796 | $0 | — | — |
| Cost of revenue | $4,231 | — | — | — |
| Gross profit | $17,565 | — | — | — |
| Selling, general & administrative | $6.8M | — | — | — |
| Research and development | $2.1M | $492,660 | $954,793 | — |
| Operating expenses | $8.9M | $3.1M | $3.9M | — |
| Operating income | -$8.9M | -$3.1M | -$3.9M | — |
| Interest expense | $66,020 | $248,366 | $218,705 | — |
| Net income | -$8.6M | -$2.4M | -$4.8M | — |
| Balance Sheet | ||||
| Current assets | $4.8M | $4.7M | $28,739 | — |
| Total assets | $5.6M | $6.2M | $148,592 | — |
| Current liabilities | $7.4M | $2.0M | $5.8M | — |
| Total liabilities | $7.4M | $2.0M | $5.9M | — |
| Stockholders' equity | -$1.8M | $4.2M | -$5.8M | -$7.1M |
| Cash Flow Statement | ||||
| Cash from operations | -$5.4M | -$3.9M | -$480,953 | — |
| Stock-based compensation | $2.4M | $1.8M | $1.2M | — |
Shares outstanding 36.3M · Free float 32.4%
Annual filing data through FY ended December 31, 2025; float as of July 15, 2026.